Prognosis and Course of COVID-19 Infection in Hospitalised Patients

NCT04752085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 345

Last updated 2023-01-26

No results posted yet for this study

Summary

The aim of the cohort prospective observational study is to define the major factors influencing the course of COVID-19 infections and its prognosis in hospitalised patients.

The investigators plan to include 300 patients hospitalised with COVID-19 infection.

The phone contacts with patients are due after 90 and 180 days after discharge.

Conditions

  • Covid19
  • SARS-CoV Infection

Interventions

DIAGNOSTIC_TEST

Chitotriosidase activity

The chitotriosidase activity will be measured in all the subjects

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Principal Investigators

  • Olga Mironova, PhD · Sechenov University

  • Ekaterina Schelkanovtseva, MD · Sechenov University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-03-01
Completion
2023-01-10

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04752085 on ClinicalTrials.gov